Perry A. Karsen, Director at Intellia Therapeutics, Inc. (NTLA), sold 177,528 shares at $52.52 ($9.5M) on 2020-12-17, disclosed to the SEC on 2020-12-18.
Open-market sale of $9.5M NTLA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.52 | 21,978 | $1.2M | 12.1% |
| 2 | $52.52 | 21,978 | $1.2M | 12.1% |
| 3 | $53.69 | 45,450 | $2.4M | 25.7% |
| 4 | $53.69 | 45,450 | $2.4M | 25.7% |
| 5 | $54.33 | 21,336 | $1.2M | 12.2% |
| 6 | $54.33 | 21,336 |
| $1.2M |
| 12.2% |
| Total | $53.55 avg | 177,528 | $9.5M | 100% |
| Filing → |
| CELG | SELL | 2015-05-15 | $5.4M | — | Filing → |
| CELG | SELL | 2015-02-13 | $3.4M | — | Filing → |
| CELG | SELL | 2015-01-02 | $2.2M | — | Filing → |